Cancer Immunotherapy 101: CAR-T Cells

Cancer Immunotherapy 101: CAR-T Cells

In this presentation at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center 2018 Cancer Biology Retreat, Dr. Eduardo Davila explains how chimeric antigen receptor (CAR)-T cell immunotherapy works by elucidating how CAR-T cells are created and the process for delivering them to patients. Although CAR-T cells have been around since the 1980s, Dr. Davila briefly describes the explosion in research surrounding them over the past decade thanks in large part to Dr. Carl June, who also spoke at the retreat.


Created by

University of Maryland Medical Center - Physician Video Channel

Related Presenters

Eduardo Davila, PhD

Eduardo Davila, PhD

Associate Professor of Microbiology and Immunology at the University of Maryland School of Medicine

Eduardo Davila, PhD is an Associate Professor of Microbiology and Immunology at the University of Maryland School of Medicine.

View full profile